Bruker (BRKR) Non Operating Interest Expenses (2010 - 2026)

Bruker (BRKR) has reported Non Operating Interest Expenses for 10 consecutive years, with $17.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Interest Expenses rose 13.38% year-over-year to $17.8 million; the trailing twelve-month figure through Jun 2026 stood at $61.5 million (up 9.82% YoY), and the FY2025 full-year result was $60.3 million, up 25.89% from the prior year.
• Non Operating Interest Expenses grew to $17.8 million in Q2 2026 per BRKR's latest filing, from $12.2 million in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $20.3 million in Q3 2025 and bottomed at -$4.0 million in Q2 2022.
• Historically, Non Operating Interest Expenses has averaged $9.0 million across 5 years, with a median of $8.1 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Non Operating Interest Expenses jumped 302.56% in 2024, then slipped 28.21% in 2025.
• Over 5 years, Non Operating Interest Expenses stood at $4.3 million in 2022, then climbed by 2.33% to $4.4 million in 2023, then jumped by 254.55% to $15.6 million in 2024, then retreated by 28.21% to $11.2 million in 2025, then surged by 58.93% to $17.8 million in 2026.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $17.8 million, $12.2 million, and $11.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.